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We report on a patient with clusterlike headache and multiple brain metastases of lung cancer. Initially,
cluster headache was suggested clinically by characteristic symptoms without any focal central nervous
system signs. However, magnetic resonance imaging demonstrated multiple brain metastases. It is possible
that tumor necrosis factor may have played a role in initiating the clusterlike headache.
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Among the diagnostic criteria of cluster headache put forward by the International Headache Society,
neuroradiological investigations should not demonstrate any pathological or morphological lesion in the central nervous
system. Recent reviews described the association of clusterlike headache with anatomical disturbances of the central
and peripheral nervous systems.1–9 We report here the occurrence of clusterlike headache in a patient with multiple
brain metastases. The results of early neurological examinations were normal with the exception of the tactile
hypesthesia of the region of the left ophthalmic branch of the trigeminal nerve. Neuroradiological investigations revealed
multiple brain metastases.
CASE HISTORY
For 5 weeks prior to investigation, a 55-year-old taxi driver had severe sharp pains in the left eye and temporal
region. The pains were excruciating and usually lasted 30 to 60 minutes. The attacks were associated with conjunctival
injection, lacrimation, and nasal congestion. At the beginning of the symptoms, the pain occurred once daily, but
increased in frequency over time. Common analgesics had no benefit. Prior to the onset of the symptoms, he had never
been admitted to hospital. Since adolescence, he had been a heavy smoker.
On the initial neurological examination, the only noteworthy finding was hypesthesia in the distribution of the first
division of the left trigeminal nerve. Since he had never previously experienced headache, a head CT scan was
performed; the result was the possibility of several cerebral metastases of a systemic tumor. The MRI findings were
also positive (Figure). In a search for the primary tumor, the following examinations were performed: chest x-ray and
CT scan, radionuclide bone scan, ultrasound and radionuclide scans of the thyroid gland, abdominal and pelvic
ultrasound scans, prostate ultrasound scan and proctoscopy. None of these examinations demonstrated the presence
of a primary tumor. To obtain a histological diagnosis of the brain metastases, CT-guided brain biopsy was performed
from different levels of the
left parietal lobe. The cytological examination revealed malignant epithelial tumor (suspected to be of pulmonary origin).
The following tumor marker levels were measured: carcinoembryonic antigen 15.68 ng/mL (normal: < 4 g/ L), tissue
polypeptide antigen 7.88 U/mL (normal: < 4 U/mL), and prostate specific antigen 0.12 ng/mL (normal: < 3 ng/mL). Six weeks
following the onset of the pain, a severe right hemiparesis developed with signs that the corticospinal tract was affected. The
patient became diabetic. In time, brain irradiation was administered.
At this point. he developed bilateral femoro-popliteal thrombosis, followed by pulmonary embolism. At a later stage, he
exhibited severe cardiorespiratory insufficiency, and was admitted to the Department of Pulmonology where he died. (The first
neurological examination took place in March 1994 and he died in July 1994.)
Autopsy showed that the primary cause of death was pulmonary embolism. The basic illness was bronchogenic
carcinoma in the left superior lobe. Other autopsy findings were bilateral thrombosis in the femoral vein, cerebral edema, and
herniation of the cerebellar tonsils.
COMMENTS
The pathogenesis of cluster headache is unknown.10 However, several lines of evidence suggest that the final common
pathway to pain and the periodicity of cluster headache involves the trigeminovascular system as in migraine,11–14 or a lesion
in and around the cavernous portion of the carotid artery15 and the hypothalamic–pituitary axis.16
Recent studies of the neuroimmuno-modulatory system have suggested important roles of inter-leukin-1 (IL-1) and tumor
necrosis factor (TNF) in the pathogenesis of cluster headache.17 The development of TNF in patients with malignant tumors
is more frequent than that in healthy individuals.18
Tumor necrosis factor, IL-1, and interferons control the local and systemic events of the immune response, inflammation,
and the hypothalamic-pituitary-adrenal axis.17
Interleukin-1 increases the synthesis of substance P in the painful area of cluster headache patients, and this may be the
first step of the cluster attack.17 We suspect that TNF and IL-1 may have played basic roles in initiating cluster headache in
our patient with multiple brain metastases of lung cancer.
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